Francisco Brito

Dr. Francisco Brito


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2026 in Viruses
Verified
Journal Article
Open access
PDF file
Nedim KozaracNedim Kozarac
Nedim Kozarac
MRMarius Alexandru Botos Rogozsan
Marius Alexandru Botos Rogozsan
LBLaura Burgener
Laura Burgener
SBSimone de Brot
Simone de Brot
FBFrancisco Brito
Francisco Brito
LRLlorenç Grau Roma
Llorenç Grau Roma
Histopathology and immunohistochemistry (IHC) are central to COVID-19 tissue evaluation. However, conventional manual scoring is limited by its semiquantitative nature and potential observer variability. In this retrospective study of experimentally infected mice, we implemented a semi-automated digital pathology workflow using commercially available software to quantitatively assess SARS-CoV-2 nucleocapsid (N) immunolabeling in lung (n = 135) and brain (n = 67) tissues. The performance of digital quantification was evaluated against conventional manual scoring, and its association with virological and pathological parameters was assessed across different stages of disease progression. Digital IHC quantification demonstrated strong agreement with manual scoring in both lung [R = 0.94, p < 0.0001, concordance correlation coefficient (CCC) = 0.95] and brain [R = 0.98, p < 0.0001; CCC = 0.977], demonstrating concordance between the two approaches. In addition, digital SARS-CoV-2 N immunolabeling quantification showed significant positive correlations with viral RNA levels, infectious viral titers, and histopathological scores, supporting its association with independent measures of SARS-CoV-2 infection and lesions. Although computational image analysis requires additional infrastructure, technical expertise, and increased analysis time, it provides an objective continuous quantitative measure of SARS-CoV-2 N immunolabeling that complements conventional manual assessment and may reduce observer-dependent variability.

15 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Nedim KozaracNedim Kozarac
Nedim Kozarac
MRMarius Alexandru Botos Rogozsan
Marius Alexandru Botos Rogozsan
LBLaura Burgener
Laura Burgener
SBSimone de Brot
Simone de Brot
FBFrancisco Brito
Francisco Brito
LRLlorenç Grau Roma
Llorenç Grau Roma
Histopathology and immunohistochemistry (IHC) are central to COVID-19 tissue evaluation. However, conventional manual scoring is limited by certain subjectivity and its semiquantitative nature. In this retrospective study of experimentally infected mice, we implemented a deep learning-based digital pathology workflow using com-mercially available software to quantitatively assess SARS-CoV-2 antigen burden in lung (n=135) and brain (n=67) tissues. The performance of digital quantification was evaluated against conventional manual scoring, and its biological relevance was as-sessed by correlation with established virological and pathological parameters across different stages of disease progression. Digital IHC quantification demonstrated near-perfect agreement with manual scoring in both lung [R=0.94, p< 0.0001, concord-ance correlation coefficient (CCC)=0.969] and brain (R=0.98, p< 0.0001; CCC=0.98) in-dicating high reproducibility and accuracy. In addition, digital antigen quantification showed significant positive correlations with viral RNA levels, infectious viral titers, and histopathological scores, indicating that it provides biologically meaningful readout of SARS-CoV2 infection. Although computational image analysis requires ad-ditional infrastructure, technical expertise, and increased analysis time, these invest-ments provide a more objective and reproducible alternative to the traditional manual gold standard while generating quantitative data that enable a more precise assess-ment of SARS-CoV-2–associated disease.